T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Broadcom
AVGO
|
+$2.74B |
| 3 |
Microsoft
MSFT
|
+$2.33B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.47B |
| 5 |
GE Aerospace
GE
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.42B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.44B |
| 3 |
Apple
AAPL
|
+$2.42B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.3B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.73% |
| 2 | Financials | 12.11% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Healthpeak Properties
DOC
$14.3B
| $17.7M | ﹤0.01% |
1,013,409
-1,185
| -0.1% | -$21K |
|
977
Essential Properties Realty Trust
EPRT
$6.71B
| $17.6M | ﹤0.01% |
550,503
-345,837
| -39% | -$11M |
|
978
UDR
UDR
$12.2B
| $17.5M | ﹤0.01% |
429,738
-2,548
| -0.6% | -$106K |
|
979
TriNet
TNET
$3.22B
| $17.4M | ﹤0.01% |
237,842
+910
| +0.4% | +$72.1K |
|
|
RAPP
980
Rapport Therapeutics
RAPP
$2.27B
| $17.3M | ﹤0.01% |
1,525,519
+452,311
| +42% | +$4.8M |
|
981
IES Holdings
IESC
$14.9B
| $17.3M | ﹤0.01% |
58,469
+991
| +2% | +$234K |
|
982
Entrada Therapeutics
TRDA
$290M
| $17.3M | ﹤0.01% |
2,567,478
-169,289
| -6% | -$1.36M |
|
983
Moderna
MRNA
$25.4B
| $17.2M | ﹤0.01% |
624,159
-18,789
| -3% | -$495K |
|
|
GLXY
984
Galaxy Digital Inc
GLXY
$4.07B
| $17.2M | ﹤0.01% |
+785,141
| New | +$15.9M |
|
985
Nordson
NDSN
$17.3B
| $16.9M | ﹤0.01% |
78,958
+179
| +0.2% | +$35.6K |
|
986
Columbia Banking Systems
COLB
$9.18B
| $16.9M | ﹤0.01% |
722,409
+65,115
| +10% | +$1.51M |
|
987
C.H. Robinson
CHRW
$17.5B
| $16.8M | ﹤0.01% |
175,526
+3,498
| +2% | +$328K |
|
988
Aecom
ACM
$8.19B
| $16.8M | ﹤0.01% |
149,056
+12,097
| +9% | +$1.26M |
|
989
Arcos Dorados Holdings
ARCO
$1.71B
| $16.8M | ﹤0.01% |
2,129,756
-8,404,510
| -80% | -$63.6M |
|
990
SoFi Technologies
SOFI
$23.8B
| $16.7M | ﹤0.01% |
919,541
+49,778
| +6% | +$656K |
|
991
Coherent
COHR
$64B
| $16.6M | ﹤0.01% |
186,282
-176,494
| -49% | -$12.7M |
|
992
Roivant Sciences
ROIV
$26.2B
| $16.6M | ﹤0.01% |
1,471,223
+1,210,181
| +464% | +$13.1M |
|
993
ePlus
PLUS
$2.31B
| $16.6M | ﹤0.01% |
229,905
+2,732
| +1% | +$180K |
|
|
KMTS
994
Kestra Medical Technologies
KMTS
$1.63B
| $16.5M | ﹤0.01% |
997,196
+147,778
| +17% | +$3.23M |
|
995
Euronet Worldwide
EEFT
$2.78B
| $16.5M | ﹤0.01% |
162,728
-323,698
| -67% | -$33.5M |
|
996
Skyworks Solutions
SWKS
$10.5B
| $16.5M | ﹤0.01% |
221,321
-9,410
| -4% | -$628K |
|
997
Bausch + Lomb
BLCO
$6.06B
| $16.3M | ﹤0.01% |
1,249,313
-32,587
| -3% | -$392K |
|
|
CPRX
998
DELISTED
Catalyst Pharmaceutical
CPRX
| $16M | ﹤0.01% |
735,698
-241,925
| -25% | -$5.71M |
|
999
Paycom
PAYC
$10.1B
| $15.9M | ﹤0.01% |
68,593
-1,028
| -1% | -$244K |
|
1000
Bunge Global
BG
$21.7B
| $15.8M | ﹤0.01% |
196,604
-4,373
| -2% | -$344K |
|
Similar funds
T. Rowe Price Associates's Q2 2025 Portfolio in Review
As of Q2 2025, T. Rowe Price Associates held 3,193 positions worth $883B, up 8.8% from $812B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2025 filing shows 153 new, 2,010 increased, 803 reduced and 136 closed positions. Its largest new stake was Ralliant Corp: 4,667,638 shares worth $226M. The largest sale was Amazon, an estimated $3.42B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q2 2025 buy was Ralliant Corp: 4,667,638 shares worth $226M.
- T. Rowe Price Associates added most to NVIDIA in Q2 2025, an estimated $3.94B increase.
- T. Rowe Price Associates's biggest Q2 2025 reduction was Amazon, cutting an estimated $3.42B.
- T. Rowe Price Associates fully exited US Steel in Q2 2025, selling an estimated $146M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $883B portfolio in Q2 2025.
- T. Rowe Price Associates opened 153 new positions and closed 136 in Q2 2025.
- T. Rowe Price Associates's portfolio value rose 8.8% quarter-over-quarter to $883B.
Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.